Clinical, mechanistic, and therapeutic landscape of cutaneous fibrosis
Science Translational Medicine · 25.09.2024 · 16 (766)
DOI: 10.1126/scitranslmed.adn7871 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science Translational Medicine, erschienen am 25.09.2024. Verfasst von Dayan J Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Plastic and Reconstructive Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA. Hauptthemen laut MEDLINE: Fibrosis, Skin Diseases, Skin. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.
Abstract (Originalsprache)
When dysregulated, skin fibrosis can lead to a multitude of pathologies. We provide a framework for understanding the wide clinical spectrum, mechanisms, and management of cutaneous fibrosis encompassing a variety of matrix disorders, fibrohistiocytic neoplasms, injury-induced scarring, and autoimmune scleroses. Underlying such entities are common mechanistic pathways that leverage morphogenic signaling, immune activation, and mechanotransduction to modulate fibroblast function. In light of the limited array of available treatments for cutaneous fibrosis, scientific insights have opened new therapeutic and investigative avenues for conditions that still lack effective interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Division of Plastic and Reconstructive Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA.
- Department of Dermatology, Stanford University School of Medicine, Redwood City, CA 94063, USA.
- Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
ORCID-Profile: Dayan J Li, Charlotte E Berry, Derrick C Wan, Michael T Longaker
Förderung
- NIAMS NIH HHS
Zitieren
APA
Li, D. J., Berry, C. E., Wan, D. C., & Longaker, M. T. (2024). Clinical, mechanistic, and therapeutic landscape of cutaneous fibrosis. Science Translational Medicine, 16(766). https://doi.org/10.1126/scitranslmed.adn7871
Vancouver
Li DJ, Berry CE, Wan DC, Longaker MT. Clinical, mechanistic, and therapeutic landscape of cutaneous fibrosis. Science Translational Medicine. 2024;16(766). doi:10.1126/scitranslmed.adn7871
BibTeX
@article{Li2024,
author = {Li, Dayan J and Berry, Charlotte E and Wan, Derrick C and Longaker, Michael T},
title = {Clinical, mechanistic, and therapeutic landscape of cutaneous fibrosis},
journal = {Science Translational Medicine},
year = {2024},
volume = {16},
number = {766},
doi = {10.1126/scitranslmed.adn7871}
}
EUVIMED